Medical devices deserves an expert voice.

Asianet Newsable on MSN reports on this development. Read the source and add your perspective on what it means for your industry.

Consider: What does this development mean for businesses or customers in medical devices?

Kerala’s chief minister announced state support for new medical device parks and faster approvals, and unveiled a KMDIA strategic roadmap 2026–2031 aiming to scale local manufacturing and global-market products. The plan includes a proposed Medical Devices City with shared facilities, cleanrooms and quality-control labs to lower entry costs for MSMEs and start-ups.

Consider how proposed park infrastructure, single-window approvals and shared facilities could affect site selection, regulatory timelines and capital planning for device manufacturers in the region.

Consider: What specific incentives, land allocation timelines and compliance requirements will the state offer to manufacturers planning facilities in the proposed medical device parks?

Yahoo Finance reports on this development. Read the source and add your perspective on what it means for your industry.

Consider: What does this development mean for businesses or customers in medical devices?

Qosina is serving as the sole Educational Sponsor and a Supporting Sponsor of Next-Gen MedTech Exchange Ireland 2026, providing components for hands-on educational sessions at the Galway event focused on catheter innovation, processing technology and future MedTech topics.

Consider opportunities for suppliers and device developers to engage in hands‑on technical education and component-level collaboration at regional MedTech events.

Consider: How will Qosina measure the educational impact of providing components, and what follow-up collaboration opportunities will be made available to participating engineers?

Maharashtra FDA reported markups up to 2,841% on some surgical consumables and devices, prompting the commissioner to seek a national review of pricing rules. NATHEALTH responded calling for an evidence‑based, differentiated pricing framework balancing affordability, transparency and the costs of safe device delivery.

Consider potential regulatory scrutiny, price-monitoring pilots and pressure for differentiated pricing rules that could affect procurement, margin management and contract terms for hospitals and suppliers.

Consider: What data sources and methodology will regulators use to distinguish commoditised consumables from complex devices when designing any differentiated pricing or margin controls?

Share practical expertise grounded in the linked industry sources and your own experience.

Consider: What should customers understand before making an important decision?

Share practical expertise grounded in the linked industry sources and your own experience.

Consider: Which priorities will matter most over the coming years, and why?